Strategic Financial Concepts LLC Makes New $1.54 Million Investment in Silicon Laboratories Inc. (NASDAQ:SLAB)

Strategic Financial Concepts LLC bought a new position in Silicon Laboratories Inc. (NASDAQ:SLAB) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 12,422 shares of the semiconductor company’s stock, valued at approximately $1,543,000.

Other institutional investors also recently made changes to their positions in the company. Wellington Management Group LLP lifted its position in Silicon Laboratories by 28.3% in the 3rd quarter. Wellington Management Group LLP now owns 888,382 shares of the semiconductor company’s stock worth $102,670,000 after buying an additional 195,997 shares in the last quarter. Point72 Asset Management L.P. acquired a new stake in shares of Silicon Laboratories during the 3rd quarter valued at about $7,408,000. FMR LLC boosted its position in shares of Silicon Laboratories by 1.1% during the 3rd quarter. FMR LLC now owns 4,843,370 shares of the semiconductor company’s stock valued at $559,748,000 after acquiring an additional 54,708 shares in the last quarter. Schwartz Investment Counsel Inc. boosted its position in shares of Silicon Laboratories by 17.9% during the 3rd quarter. Schwartz Investment Counsel Inc. now owns 230,000 shares of the semiconductor company’s stock valued at $26,581,000 after acquiring an additional 35,000 shares in the last quarter. Finally, SG Americas Securities LLC boosted its position in shares of Silicon Laboratories by 1,106.4% during the 4th quarter. SG Americas Securities LLC now owns 23,791 shares of the semiconductor company’s stock valued at $2,955,000 after acquiring an additional 21,819 shares in the last quarter.

Insider Activity at Silicon Laboratories

In other news, Director William G. Bock sold 2,000 shares of Silicon Laboratories stock in a transaction on Wednesday, January 22nd. The shares were sold at an average price of $140.77, for a total value of $281,540.00. Following the completion of the sale, the director now owns 32,115 shares in the company, valued at $4,520,828.55. The trade was a 5.86 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Navdeep S. Sooch sold 2,360 shares of Silicon Laboratories stock in a transaction on Wednesday, February 5th. The shares were sold at an average price of $149.00, for a total transaction of $351,640.00. Following the completion of the sale, the director now owns 400,567 shares of the company’s stock, valued at $59,684,483. This represents a 0.59 % decrease in their position. The disclosure for this sale can be found here. 1.72% of the stock is owned by company insiders.

Silicon Laboratories Trading Up 2.6 %

SLAB opened at $146.38 on Tuesday. The company’s 50 day moving average is $130.38 and its 200-day moving average is $117.36. Silicon Laboratories Inc. has a 1-year low of $94.00 and a 1-year high of $154.91. The company has a market cap of $4.75 billion, a P/E ratio of -24.64 and a beta of 1.16.

Silicon Laboratories (NASDAQ:SLAB) last posted its quarterly earnings results on Tuesday, February 4th. The semiconductor company reported ($0.11) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.11). Silicon Laboratories had a negative net margin of 32.69% and a negative return on equity of 10.46%. The company had revenue of $166.25 million for the quarter, compared to the consensus estimate of $166.09 million. During the same period last year, the company posted ($1.19) EPS. The firm’s quarterly revenue was up 91.4% compared to the same quarter last year. On average, equities analysts forecast that Silicon Laboratories Inc. will post -0.47 EPS for the current year.

Analyst Ratings Changes

Several equities analysts recently issued reports on the stock. StockNews.com raised shares of Silicon Laboratories from a “sell” rating to a “hold” rating in a report on Thursday, February 6th. Susquehanna assumed coverage on shares of Silicon Laboratories in a research note on Tuesday, December 17th. They set a “neutral” rating and a $130.00 price target for the company. Stifel Nicolaus boosted their price target on shares of Silicon Laboratories from $135.00 to $145.00 and gave the stock a “buy” rating in a research note on Monday, January 6th. JPMorgan Chase & Co. decreased their price objective on shares of Silicon Laboratories from $150.00 to $135.00 and set an “overweight” rating for the company in a report on Tuesday, November 5th. Finally, Morgan Stanley decreased their price objective on shares of Silicon Laboratories from $123.00 to $97.00 and set an “equal weight” rating for the company in a report on Tuesday, November 5th. Six analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $136.20.

Silicon Laboratories Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.